Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CERE

Cerevel Therapeutics (CERE) Stock Price, News & Analysis

Cerevel Therapeutics logo

About Cerevel Therapeutics Stock (NASDAQ:CERE)

Advanced Chart

Key Stats

Today's Range
$44.96
$44.96
50-Day Range
$40.30
$44.96
52-Week Range
$19.59
$44.99
Volume
N/A
Average Volume
1.71 million shs
Market Capitalization
$8.19 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CERE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cerevel Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CERE Stock News Headlines

Your blueprint for crypto wealth
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
See More Headlines

CERE Stock Analysis - Frequently Asked Questions

Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) posted its earnings results on Wednesday, November, 1st. The biotechnology company reported ($0.61) EPS for the quarter, topping analysts' consensus estimates of ($0.63) by $0.02.
Read the conference call transcript
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cerevel Therapeutics investors own include NVIDIA (NVDA), Medtronic (MDT), Advanced Micro Devices (AMD), Tesla (TSLA), Meta Platforms (META), First Solar (FSLR) and Datadog (DDOG).

Company Calendar

Last Earnings
11/01/2023
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Coal & Consumable Fuels
Current Symbol
NASDAQ:CERE
CIK
767884
Fax
N/A
Employees
300
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.73)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$432.84 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-98.94%
Return on Assets
-45.07%

Debt

Debt-to-Equity Ratio
0.60
Current Ratio
10.22
Quick Ratio
10.22

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.71 per share
Price / Book
12.12

Miscellaneous

Outstanding Shares
182,200,000
Free Float
172,903,000
Market Cap
$8.19 billion
Optionable
Optionable
Beta
1.40

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:CERE) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners